Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China
· Delayed Price · Currency is CNY 20.56
+0.18 (0.88%)
Mar 28, 2025, 3:00 PM CST
SHA:600161 Revenue
In the year 2024, Beijing Tiantan Biological Products had annual revenue of 6.03B CNY with 16.44% growth. Beijing Tiantan Biological Products had revenue of 1.96B in the quarter ending December 31, 2024, with 69.06% growth.
Revenue
6.03B
Revenue Growth
+16.44%
P/S Ratio
6.77
Revenue / Employee
1.24M
Employees
4,858
Market Cap
40.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.03B | 851.42M | 16.44% |
| Dec 31, 2023 | 5.18B | 919.14M | 21.57% |
| Dec 31, 2022 | 4.26B | 149.15M | 3.63% |
| Dec 31, 2021 | 4.11B | 666.56M | 19.35% |
| Dec 31, 2020 | 3.45B | 163.74M | 4.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition